Pharmafile Logo

Clinical trials explained: Why iconography matters…

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial materials.

How many times a day do we see, and use, icons?

The answer to that question is likely to be lots, and probably more than we realise. Especially when we think about a ‘thumbs up’ or heart emoji in our favourite apps or on social media, road and tourist attraction signs that direct us when we’re travelling, websites when we’re tracking down information – the list goes on. The fact that they appear in so many different areas of our daily lives just go to show how useful they can be as an alternative form of communication.

Icons as visual language

Iconography comes from the Greek words ‘eikon’, meaning image, and ‘graphe’, meaning to write. So, iconography is ‘image-writing’ (which as a description really does sum it up!).

In today’s world, many icons are immediately recognisable — they’re used repeatedly across different industries and different products to represent the same actions and scenarios, thereby creating a universal language. For example, a simple ‘glyph’ icon such as those used for the weather forecast are instantly identifiable. More specific and detailed icons are also commonly used and tend to take the place of words to convey a more visually appealing design, and to help reader usability and understanding.

Which is why, in healthcare communications, the use of icons can be a fantastic addition. At Cuttsy+Cuttsy, we have lots of experience in developing support materials for clinical trials, which has meant we’ve spent a lot of time thinking about and developing icons, and how they can be used in the best possible way to elevate communications.

Icons in clinical trials

It can be daunting for patients when faced with the prospect of joining a clinical trial. Fear and a lack of understanding about what’s required of them are significant barriers to a patient agreeing to be involved. And even once they are recruited to a trial, it’s vital to provide them with information that they are able to easily understand and action to encourage their continued involvement.

When we’re creating materials for clinical trials, we explore if and how icons could be developed to make information more accessible for patients. When used appropriately, icons often work faster than words alone, and they can help to enhance health literacy and enable readers to navigate their way through detailed information more easily. Icons are particularly useful for visual learners, as well as people with reading difficulties or who struggle with comprehension. By facilitating the design of clear, easy-to-read page layouts, icons can also act as signposts to the important ‘need to knows’.

But what makes a good icon?

In our experience, an effective icon is one that is simple and communicates its meaning to the reader quickly. When producing content for trial participants, we always consider positioning, consistency, and design. For example, the positioning of icons can support the flow of information being provided and encourage action if it’s necessary. Consistency and familiarity of icons can help to develop trust in a study — which is essential for patient onboarding and retention whilst icon design supports understanding and engagement, as well as being an additional way to reinforce your trial identity (have you seen our blog on branding your trial yet? Check it out here. It’s also key to consider the use of colour when thinking about how icons can be used. Read more about how colour plays an important role in eliciting an emotional response and the impact that this also has in relation to clinical trials by reading our blog on colour here.

We don’t know if health literacy was something the ancient Greeks understood, but their iconographic image-writing is certainly now vital to making health information more accessible!

So, if you’d like to know more about how iconography can elevate and support your clinical trial work, let’s talk.

‍You can read all our latest clinical trials explained blogs here.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy welcomes new team members

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account Executive; Vicki, a creative Graphic Designer; and Jo, a detail-driven Artworker

Designing with patients in mind: How to build more inclusive clinical trials

Discover how patient-centred design transforms inclusive clinical trials. Learn to overcome trial recruitment challenges by listening to patients and creating studies that fit real lives.

Why fresh patient voices are critical to improve clinical trials outcomes

Discover why diverse patient voices, especially first-time participants, are key to improving clinical trials. Boost recruitment, retention, and patient-centric research.

Using patient personas to add a personal touch to clinical trial recruitment and retention

Discover how patient personas can revolutionise clinical trial recruitment and retention. Personalise outreach, build trust, and improve patient engagement.

A month of insights: Key takeaways from May’s conferences

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Motivations that matter: Understanding clinical trial participation to create better research

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to...

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

AI and away we go: key insights from Reuters Pharma 2025

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.